Company intelligence / Profile preview

WorldQuant Foundry

New York, New York, USAworldquantfoundry.com ↗

Ownership: Private
Development stage: Other

Overview

WorldQuant Foundry does not conduct clinical trials itself but serves as an incubator/platform for launching deep-tech startups in healthcare and other sectors. It has recently launched Alpha Deal—an AI-powered deal intelligence platform—and appointed Dr. Christopher Mason as Senior Healthcare Advisor to spearhead AI-driven healthcare innovation in diagnostics, therapeutics, and precision medicine.

No direct clinical results are reported at the WQF level.

Therapeutic areas: OtherOncology
Modalities: Artificial intelligence platformsSmall moleculeBiologicGene therapy
Industry: Investors

Partnerships

BioAstraEntrepreneurs/founders in deep-tech fields

Beyond the preview

Go deeper on WorldQuant Foundry.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on WorldQuant Foundry.

Explore the full profile